Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Tidmarsh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Liposomal doxorubicin and the accelerated approval processGeorge Tidmarsh
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
The generic drug shortageGeorge Tidmarsh
Disease Models & Mechanisms|July 6, 2013
Linking academia and industry to bring drugs to the clinic: an interview with George TidmarshGeorge Tidmarsh
Pediatrics|December 15, 2023
Angiotensin-II Use for Refractory Hypotension in an Infant With Bilateral Renal AgenesisSheila Razdan, Alexis S Davis, George Tidmarsh, et al.
Biochimica Et Biophysica Acta|December 26, 2015
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cellsPeter P Ruvolo, Vivian R Ruvolo, Christopher B Benton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Liposomal doxorubicin and the accelerated approval processGeorge Tidmarsh
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
The generic drug shortageGeorge Tidmarsh
Disease Models & Mechanisms|July 6, 2013
Linking academia and industry to bring drugs to the clinic: an interview with George TidmarshGeorge Tidmarsh
Pediatrics|December 15, 2023
Angiotensin-II Use for Refractory Hypotension in an Infant With Bilateral Renal AgenesisSheila Razdan, Alexis S Davis, George Tidmarsh, et al.
Biochimica Et Biophysica Acta|December 26, 2015
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cellsPeter P Ruvolo, Vivian R Ruvolo, Christopher B Benton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphomaJohn P Leonard, Morton Coleman, Lale Kostakoglu, et al.
Pageof 1